期刊文献+

选择性钙通道阻滞剂构效关系及其作用的研究进展

下载PDF
导出
摘要 钙拮抗剂又称钙通道阻滞剂fcalcium channel blocker,CCB),是指在通道水平上选择性阻滞钙离子进入细胞内。降低细胞内钙离子浓度的一类药物。早在18世纪后期。钙离子内流可引起肌肉收缩已为人所知,但对其进入细胞的机制尚不清楚。1963年Knoll和Hoechest公司首次合成钙通道阻滞剂维托帕米,为心脑血管疾病的治疗翻开了崭新的一页。细胞内钙有极其重要的生理功能,
出处 《中国民族民间医药》 2009年第17期4-6,共3页 Chinese Journal of Ethnomedicine and Ethnopharmacy
  • 相关文献

参考文献38

  • 1Onose Y, Oki T, Yanachda H, et al.Effect of cilnidipine on left ventricular diastolic fimction in hyperlensive patients as assessed hy pulsed Doppler e choeardiography and pulsed lissue Doppler imagine [J] . Jpn Cir J, 2001, 65: 305-309.
  • 2Rose GW, Kanno Y, Ikebukuro H, et al. Cilnidipine is as effective as bennazepril for control blood pressure and proteinuria in hypertensive patients with benign nephrosclerosis [J] .Hypertens Res, 2001, 24: 377-383.
  • 3Dhein S, Salameh A, Berkels R, et al. Dual mode of action of dihydropyri dine calcium antagonists: a roe for ntric oxde [J] .Drugs, 1999, 58 (3) 397-404.
  • 4Anon. The sixth report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure [J] . Arch Intern Med 1997, 157 (21): 2413-2446.
  • 5杨宝峰主编.药理学(第六版).北京:人民卫生出版社,2007.203-204.
  • 6Kazuyuki MS, Masahiro N, Tetsuya I, et al. Studies on novel and chiral 1. 4-dihydropyridines. Tetrahedron, 1997, 53 (12): 4279.
  • 7Keiji I. Keiichi O, Hiroki M, et al. Effects of MPC-1304, a novel Ca^2+ entry blocker on α-adrenoeeptor-nlediated pressor responses. Eur J Pharmacol, 1993, 238 (2-3): 283.
  • 8Luciano C-uarneri, Patrizia Angelico, Marina Ibba, et al. Pharmacological in vilru studies of new 1, 4-dihydrupyridine calcium antagonist Lereandipine. Arzneim Forsch/Drug Res. 1996, 46 (1): 15.
  • 9Kojda G, Klaus W, Werner G, el al. The influence of endothelium on the action of PGF2α and some dihydropyridine-type calcium antagonist in porcine basilar arteries[J].Basic Res Cardiol, 1991, 86 (3): 254-265.
  • 10Gunther J, Dhein S. Rosen R, et al. Nitric oxide (EDRF) enhances the vasorelaxing effect of nitrendipine in various isolated arteries [J] .Basic Res Cardiol, 1992, 87 (5): 452-460.

二级参考文献18

  • 1[1]DHEIN S, SALAMEH A, BERKELS R, et al. Dual mode of action of dihydropyridine calcium antagonists: a role for nitric oxide[J]. Drugs, 1999, 58(3):397-404.
  • 2[2]Anon. The sixth report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure[J]. Arch Intern Med, 1997, 157(21):2413-2446.
  • 3[3]LUSCHER TF, COSENTINO F. The classification of calcium antagonists and their selection in the treatment of hypertension: a reappraisal[J]. Drugs, 1998, 55(4):509-517.
  • 4[4]OKABE K, TERADA K, KITAMURA K, et al. Selective and long-lasting inhibitory action of the dihydropyridine derivative, CV-4093, on calcium currents in smooth muscle cells of the rabbit pulmonary artery[J]. J Pharmacol Exp Ther, 1987, 243(2):703-710.
  • 5[5]CHEER SM, MCCLELLAN K. Manidipine: a review of its use in hypertension[J]. Drugs, 2001, 61(12):1777-1799.
  • 6[6]PFAFFENDORF M, MATHY MJ, van ZWIETEN PA. Effects of manidipine and other calcium antagonists on rat renal arcuate arteries[J]. Am Heart J, 1993, 125(2 Pt 2): 571-577.
  • 7[7]FOGARI R, ZOPPI A, MUGELLINI A, et al. Effect of low-dose manidipine on ambulatory blood pressure in very elderly hypertensives[J]. Cardiovasc Drugs Ther, 1999, 13(3):243-248.
  • 8[8]MANCIA G, OMBONI S, AGABITI-ROSEI E, et al. Antihypertensive efficacy of manidipine and enalapril in hypertensive diabetic patients[J]. J Cardiovas Pharmacol, 2000, 35(6):926-931.
  • 9[9]HASE MI, HASE O, IGAWA S, et al. Reduction of left ventricular mass by manidipine hydrochloride[J]. Am J Hypertens, 1998, 11(4 Pt 2):81A.
  • 10[10]TAKABATAKE T, USHIOGI Y, ISE T, et al. Effect of calcium antagonist, manidipine hydrochloride, on renal hemodynamics and tubuloglomerular feedback in spontaneously hypertensive rats[J]. Am Heart J, 1993, 125(2 Pt 2):578-581.

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部